Gaurav Shah is a Macular Degeneration (AMD) physician affiliated with West Coast Retina Medical Group. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 17 Nov 2026
Gaurav Shah, MD, is affiliated with West Coast Retina Medical Group. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 21 companies.
- Top research focus: Macular Degeneration (AMD)
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 21 companies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Sponsor: Retina Research Institute, LLC
- Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results
Sponsor: Retina Research Institute, LLC
- Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
Sponsor: Barnes Retina Institute
Industry payments
Updated 13 Nov 2026
21 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202513 payments$19,263openpaymentsdata.cms.gov ↗
- Beaver-Visitec International, Inc.Program year20251 payment
- Bausch & Lomb Americas Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
71.5%Vascular Endothelial Growth Factor Inhibitor71.5%Aflibercept100%Part B, office-administered≥34 patientsSensory organs
23.3%Corticosteroid12.4%Prednisolone Acetate100%Part D≥22 patientsPolymyxin-class Antibacterial10.8%Polymyxin B Sul-Trimethoprim100%Part D≥20 patientsCardiovascular
5.2%Beta blocker5.2%Timolol Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinalphysician.com ↗
Media & interviews
press, podcasts and appearances- Guest
One Month Till Graduation Special Episode (AAO audio)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aao.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinalphysician.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Carol Shields, MD
Wills Eye Hospital
Harry Quigley, MD
Johns Hopkins University School of Medicine